Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026

About this update from Clinical Laserthermia Systems Ab Class B

Clinical Laserthermia Systems AB OMXSTO:CLS_B:Q4 NET SALES SEK 830 THOUSANDQ4 OPERATING LOSS SEK 10,615,000CONTINUES TO MAINTAIN COMMUNICATED TARGETS FOR 2026

View stock analysis, news, and events for Clinical Laserthermia Systems Ab Class B